chloramphenicol has been researched along with Myelodysplastic Syndromes in 2 studies
Amphenicol: Chloramphenicol and its derivatives.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arber, C | 1 |
| Buser, A | 1 |
| Heim, D | 1 |
| Gratwohl, A | 1 |
| Tichelli, A | 1 |
| Passweg, JR | 1 |
| Alcindor, T | 1 |
| Bridges, KR | 1 |
1 review available for chloramphenicol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Sideroblastic anaemias.
Topics: Anemia, Sideroblastic; Anti-Bacterial Agents; Chelating Agents; Chloramphenicol; DNA, Mitochondrial; | 2002 |
1 other study available for chloramphenicol and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Topics: Chloramphenicol; Cyclosporine; Humans; Immunosuppressive Agents; Middle Aged; Myelodysplastic Syndro | 2006 |